Phase II Trial of Weekly Intravenous Gemcitabine Administration With Interferon and Interleukin-2 Immunotherapy for Metastatic Renal Cell Cancer
Titel:
Phase II Trial of Weekly Intravenous Gemcitabine Administration With Interferon and Interleukin-2 Immunotherapy for Metastatic Renal Cell Cancer
Auteur:
Neri, B. Doni, L. Gemelli, M.T. Fulignati, C. Turrini, M. Di Cello, V. Dominici, A. Maleci, M. Mottola, A. Ponchietti, R. Raugei, A. Valsuani, G. Cini, G.